Switch to:
More From Other Websites
ArQule to Present Preclinical Data for BTK Inhibitor, ARQ 531, at the 22nd Annual Congress of the... May 18 2017
ArQule to Present Clinical Data at the 2017 American Society of Clinical Oncology (ASCO) Annual... May 17 2017
Edited Transcript of ARQL earnings conference call or presentation 3-May-17 1:00pm GMT May 03 2017
Investor Network: ArQule, Inc. to Host Earnings Call May 03 2017
ArQule reports 1Q loss May 03 2017
Arqule Reports First Quarter 2017 Financial Results May 03 2017
ArQule Announces Issuance of U.S. Patent Covering Composition of Matter of Proprietary Reversible... Apr 26 2017
ArQule To Report First Quarter 2017 Financial Results On May 3, 2017 Apr 19 2017
ArQule Receives Clearance of Investigational New Drug Application from the FDA for Proprietary... Apr 11 2017
ETFs with exposure to ArQule, Inc. : April 5, 2017 Apr 05 2017
ArQule to Present at the 16th Annual Needham Healthcare Conference on April 4, 2017 Mar 28 2017
ArQule Announces Top-Line Results of Phase 3 Clinical Study of Tivantinib in Hepatocellular... Mar 27 2017
ArQule, Inc. :ARQL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
ArQule, Inc. :ARQL-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Mar 14 2017
Edited Transcript of ARQL earnings conference call or presentation 7-Mar-17 2:00pm GMT Mar 07 2017
ArQule Reports Fourth Quarter and Full Year 2016 Financial Results Mar 07 2017
ArQule To Report Fourth Quarter and Year End 2016 Financial Results On March 7, 2017 Feb 24 2017
ArQule Liver Cancer Drug Fails Phase 3 Trial Feb 20 2017
ArQule, Inc. (ARQL)’s Liver Cancer Drug Fails: What’s Next? Feb 20 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK